FATE
Fate Therapeutics Inc.
$1.39
-$0.24(-14.90%)
62
Overall
60
Value
91
Tech
36
Quality
Market Cap
$110.98M
Volume
2.06M
52W Range
$0.66 - $3.50
Target Price
$4.45
EPS Estimates Overview
| Current Quarter | $-0.31 | Next Quarter | $-0.28 |
| Current Year | $-1.1 | Next Year | $-1.02 |
| QoQ Growth | +9.7% | YoY Growth | +7.3% |
| 3Y EPS CAGR | +9.9% | Target Price | $4.45 |
| Consensus | Buy | Upside | +219.8% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | FATE | $1.39 | -14.9% | 2.06M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |